Moreover, it provides a basis for further investigation to determine if inhibiting LOX overexpression may be a useful strategy for preventing retinal vascular lesions associated with the pathogenesis of diabetic retinopathy. The gene discussed is LOX; the disease is diabetic retinopathy.